ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

When payers will pay more: Calculating — and justifying — the ROI of expensive treatments

Featured Story

When payers will pay more: Calculating — and justifying — the ROI of expensive treatments

May 22, 2013 11:53 am by | 0 Comments

Calculating the return on investment of expensive drugs and surgeries can mean good news for patients. A recent conversation among decision makers at big insurance companies also showed that payers aren’t the heartless bureaucrats they are often made out to be.Leaders from UnitedHealth Group, Blue Cross Blue Shield Minnesota and ... Read more
Telehealth startup 2nd.MD CEO says he got encouragement from Eric Topol

Telehealth startup 2nd.MD CEO says he got encouragement from Eric Topol

May 22, 2013 8:36 pm by | 0 Comments

If you’re a healthcare entrepreneur, it probably doesn’t get much better than getting encouragement from Eric Topol. It’s a bit like a celebrity endorsement. Suffice it to say, Clinton Phillips, ... Read more
Talk to a pharmacist online, improve your blood pressure. But who pays?

Talk to a pharmacist online, improve your blood pressure. But who pays?

May 22, 2013 5:13 pm by | 0 Comments

NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their pharmacists online had better blood pressure control a year after that ... Read more
EHR adoption reaches “tipping point” but challenges remain

EHR adoption reaches “tipping point” but challenges remain

May 22, 2013 4:59 pm by | 0 Comments

The Department of Health and Human Services marked a milestone this week, announcing more than 50 percent of eligible providers have adopted or used electronic health records — a goal ... Read more
Mayo Clinic-Cancer Genetics joint venture will put next-gen sequencing to work in diagnostics

Mayo Clinic-Cancer Genetics joint venture will put next-gen sequencing to work in diagnostics

May 22, 2013 4:58 pm by | 0 Comments

Now that next-generation DNA sequencing is fast enough, cheap enough and commercially available, the next challenging for innovators is finding ways to effectively apply it to everyday medicine outside of ... Read more
Merck’s insomnia drug deemed safe at low dose, but not at higher

Merck’s insomnia drug deemed safe at low dose, but not at higher

May 22, 2013 4:14 pm by | 0 Comments

WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts ... Read more

MedCitizens

Become a MedCitizen and publish your own stories and thoughts (for free and unedited) alongside the journalists at MedCity News. Click here for more MedCitizens.

Apps that Help You Manage Your Health and Food

Apps that Help You Manage Your Health and Food

The importance of healthy food cannot be stressed enough. We’ve all heard the quote by one of the central figures ... Read more

Electronic Medical Records ’ The Cloud Effect

Electronic Medical Records ’ The Cloud Effect

The most significant advantage of having cloud based Electronic Medical Records is low-cost.Research has suggested that using cloud-based solutions can ... Read more

Be ready for Electronic Medical Records

Be ready for Electronic Medical Records

The fundamental principle of any Electronic Medical Record being implemented at a practice is that all members of the practice ... Read more

Study: Patients report more complications than doctors after skin surgery

Study: Patients report more complications than doctors after skin surgery

May 22, 2013 3:34 pm by | 0 Comments

NEW YORK (Reuters Health) - More than one quarter of people being treated for non-melanoma skin cancer in their doctor's office reported some type of complication after surgery, in a ... Read more
Merrimack builds large pipeline of cancer drugs but keeps costs low

Merrimack builds large pipeline of cancer drugs but keeps costs low

May 22, 2013 2:59 pm by | 0 Comments

NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of ... Read more
SAP partners with start-up to hire people with autism

SAP partners with start-up to hire people with autism

May 22, 2013 1:59 pm by | 0 Comments

FRANKFURT (Reuters) - German software company SAP is looking to recruit people with autism as programmers and product testers, drawing on skills that can include a close attention to detail ... Read more
Fearless teen scientists are building PCR machines & finding better ways to detect cancer

Fearless teen scientists are building PCR machines & finding better ways to detect cancer

May 22, 2013 1:30 pm by | 0 Comments

At one point during my trip to FutureMed earlier this year, I found myself seated next to a young man — noticeably younger than many of the entrepreneurs and doctors-in-training ... Read more
Here’s a look at Scanadu’s Tricorder, which has raked in $100K in just a few hours on indiegogo

Here’s a look at Scanadu’s Tricorder, which has raked in $100K in just a few hours on indiegogo

May 22, 2013 9:58 am by | 0 Comments

Scanadu, one of the most high profile participants vying for the $10 million Qualcomm Tricorder X PRIZE, today lifted the veil on the design of its medical scanner via an ... Read more
Oncolytics gets good news on cancer drug Reolysin

Oncolytics gets good news on cancer drug Reolysin

May 22, 2013 9:46 am by | 0 Comments

(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients ... Read more
The perils of naming a deadly virus

The perils of naming a deadly virus

May 22, 2013 8:54 am by | 0 Comments

LONDON (Reuters) - For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of ... Read more
Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

May 22, 2013 8:52 am by | 0 Comments

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for ... Read more
GSK uses contest to advance academic researchers’ pre-clinical drug development

GSK uses contest to advance academic researchers’ pre-clinical drug development

May 22, 2013 8:42 am by | 0 Comments

It’s notoriously difficult to secure funding for the pre-clinical stage of drug development. Risk averse investors don’t want to take a chance on research where there’s a high risk of ... Read more
GlaxoSmithKline gets unprecedented antiobiotics development deal with U.S.government

GlaxoSmithKline gets unprecedented antiobiotics development deal with U.S.government

May 22, 2013 7:01 am by | 0 Comments

LONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and ... Read more